StockData
Imunon, Inc. logo

Imunon, Inc. (IMNN) stock

IMNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.58−0.03 (-5.26%)

Close on Nov 18, 2026Market cap $3.25MP/E –Yield –

Imunon net income

Net income is the profit left for shareholders after every expense, interest and tax.

Imunon's net income for the twelve months ending Mar 31, 2026 was -$14.64M. For fiscal 2025 it was -$14.50M. The highest annual figure on record is -$8.25M in fiscal 2013.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.50M–
FY2024Dec 31, 2024-$18.62M–
FY2023Dec 31, 2023-$19.51M–
FY2022Dec 31, 2022-$35.90M–
FY2021Dec 31, 2021-$20.77M–
FY2020Dec 31, 2020-$21.48M–
FY2019Dec 31, 2019-$16.85M–
FY2018Dec 31, 2018-$11.88M–
FY2017Dec 31, 2017-$20.40M–
FY2016Dec 31, 2016-$22.05M–
FY2015Dec 31, 2015-$22.46M–
FY2014Dec 31, 2014-$25.49M–
FY2013Dec 31, 2013-$8.25M–
FY2012Dec 31, 2012-$26.57M–
FY2011Dec 31, 2011-$23.22M–
FY2010Dec 31, 2010-$18.82M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026-$4.25M–
Q4 FY2025Dec 31, 2025-$4.22M–
Q3 FY2025Sep 30, 2025-$3.43M–
Q2 FY2025Jun 30, 2025-$2.74M–
Q1 FY2025Mar 31, 2025-$4.10M–
Q4 FY2024Dec 31, 2024-$4.06M–
Q3 FY2024Sep 30, 2024-$4.85M–
Q2 FY2024Jun 30, 2024-$4.79M–
Q1 FY2024Mar 31, 2024-$4.93M–
Q4 FY2023Dec 31, 2023-$4.89M–
Q3 FY2023Sep 30, 2023-$3.48M–
Q4 FY2022Dec 31, 2022-$13.23M–
Q3 FY2022Sep 30, 2022-$6.15M–
Q2 FY2022Jun 30, 2022-$6.04M–
Q1 FY2022Mar 31, 2022-$10.47M–
Q4 FY2021Dec 31, 2021-$4.22M–
Q3 FY2021Sep 30, 2021-$5.41M–
Q2 FY2021Jun 30, 2021-$5.45M–
Q1 FY2021Mar 31, 2021-$5.69M–
Q4 FY2020Dec 31, 2020-$3.01M–
Q3 FY2020Sep 30, 2020-$8.07M–
Q2 FY2020Jun 30, 2020-$5.34M–
Q1 FY2020Mar 31, 2020-$5.06M–
Q4 FY2019Dec 31, 2019-$3.10M-156.6%
Q3 FY2019Sep 30, 2019-$5.48M–
Q2 FY2019Jun 30, 2019-$5.90M–
Q1 FY2019Mar 31, 2019-$2.37M–
Q4 FY2018Dec 31, 2018$5.48M–
Q3 FY2018Sep 30, 2018-$4.66M–
Q2 FY2018Jun 30, 2018-$8.23M–
Q1 FY2018Mar 31, 2018-$4.48M–
Q4 FY2017Dec 31, 2017-$4.68M–
Q3 FY2017Sep 30, 2017-$5.67M–
Q2 FY2017Jun 30, 2017-$5.67M–
Q1 FY2017Mar 31, 2017-$5.16M–
Q4 FY2016Dec 31, 2016-$5.40M–
Q3 FY2016Sep 30, 2016-$6.41M–
Q2 FY2016Jun 30, 2016-$4.53M–
Q1 FY2016Mar 31, 2016-$5.72M–

More Imunon figures

See a number that looks wrong?